Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
ABSTRACT
Introduction
Urinary tract infections are second most (Zakaria EI ASTal., 2005). Urinary tract is
common infections in community practice. one of the most common sites of Escherichia
About 150 million people are diagnosed coli infections, particularly in females. In
with urinary tract infections each year. men it is less common and occurs after 50
Escherichia coli accounts for 75% to 90% of years of age. Urinary tract infection can be
urinary tract infection isolate causing global divided into two general anatomic categories
economy in excess of 6 billion US Dollars i) Lower urinary tract infection (urethritis,
799
Int.J.Curr.Microbiol.App.Sci (2015) 4(2): 799-805
cystitis), ii) Upper urinary tract infection individuals and also those with chronic
(pyelonephritis, prostatitis) infections (or) recurrent infections which
can add considerably to health care cost.
Urinary tract infections are dangerous in The study of emergence of fluoroquinolone
older people, diabetes, pregnant women, resistant uropathogenic Escherichia coli is of
immunosuppressant, previous infections, great concern because these pathogens
presence of urinary catheters, and presence account for 20% of all hospital acquired
of decubitus ulcer when they involve kidney infections. After notifying the role of
where the organisms cause blood fluoroquinolones in urinary tract infections
poisoning(David Rahan M.D facog; 2008). caused by Escherichia coli, the present study
Most urinary tract infections in hospital and is undertaken to study resistance towards
community setting are initially treated urinary Escherichia coli with various
empirically based on frequency of generations of fluoroquinolones.
pathogens, local antimicrobial resistance
rates and illness severity. Materials and Methods
Fluoroquinolones are preferred as initial The present study included 100 urinary
agents for empiric therapy because of high samples showing Escherichia coli isolates
bacteriological & clinical cure rates as well with urinary tract infection from the patients
as low rates of resistance among who attended to Narayana General Hospital
uropathogens. Clinical cure rates both as inpatients and outpatients for a
with fluoroquinolones for 4 to 6 weeks is period of 6 months from Nov 2007 to May
76.9%to78.3% according to 1998 .j. 2008. Patients who were excluded from the
American society of microbiology(Henry study were pregnant, lactating or
D,etal; 1998) Fluoroquinolones are also premenopausal women, patients having
recommended for patients with recurrent nosocomial UTI, patients who had taken
urinary tract infections, treatment failures antibiotic treatment within 3 days prior to
and allergies to other antimicrobial agents. initial visit, patients who had genito-urinary
tract disease or abnormalities that may
However in the past few years, preclude evaluation of therapeutic response.
fluoroquinolones have been prescribed more Patients who had gastrointestinal symptoms
frequently in out patients for the treatment or conditions that might preclude adequate
of urinary tract infections have lead to drug absorption or who were taking
increase in fluoroquinolones resistant antacids were also excluded. Patients who
Escherichia coli infections which is difficult had prolonged congenital electro cardio
to treat (Milan I cizman; et al 2001). graphic QT syndrome or who were taking
Although antibacterial agents are universally antiarrhythmic agents or other medications
recognized as having no antiviral activity, known to cause QTC prolongation or who
50% or more patients diagnosed with a viral had shown previous hypersensitivity, photo
urinary tract infection are prescribed a sensitivity to fluoroquinolones, or repeat
course of antibacterial therapy. isolates of Escherichia coli isolated from
urine of the same patient taken within 2
Fluoroquinolones resistance for Escherichia months were ignored.
coli in urinary tract infections patients being
a big problem for public health which A detailed history of patient including age,
threatens the lives of hospitalized sex, socioeconomic status, previous history
800
Int.J.Curr.Microbiol.App.Sci (2015) 4(2): 799-805
801
Int.J.Curr.Microbiol.App.Sci (2015) 4(2): 799-805
802
Int.J.Curr.Microbiol.App.Sci (2015) 4(2): 799-805
positions 248 (T) & 259 (A) confirms the bacteriological and clinical cure rates as well
high fluoroquinolones resistance rates as low rates of resistance among
towards urinary Escherichia coli in my uropathogens. But due to increased
study, which showed important region for prescriptions more frequently in past few
molecular basis to be studied by a triplex years, increase in fluoroquinolone resistant
PCR for confirmation of fluoroquinolone Escherichia coli has occurred which is
resistance in Escherichia coli uropathogenic accounting for significant morbidity and
isolates(Norbert Lehn Germany ; 1996). health care cost.
803
Int.J.Curr.Microbiol.App.Sci (2015) 4(2): 799-805
References
804
Int.J.Curr.Microbiol.App.Sci (2015) 4(2): 799-805
805